Display options
Share it on
Full text links
American Society for Clinical Investigation Free PMC Article

J Clin Invest. 1994 May;93(5):2007-13. doi: 10.1172/JCI117194.

Obesity-induced diabetes (diabesity) in C57BL/KsJ mice produces aberrant trans-regulation of sex steroid sulfotransferase genes.

The Journal of clinical investigation

E H Leiter, H D Chapman

Affiliations

  1. Jackson Laboratory, Bar Harbor, Maine 04609.

PMID: 8182132 PMCID: PMC294310 DOI: 10.1172/JCI117194
Free PMC Article

Abstract

The diabetes (db) gene is a recessive obesity mutation in the mouse capable of producing diabetes only through interaction with heretofore undefined modifiers in the genetic background of certain inbred strains. Here we identify the genetic map locations of androgen and estrogen sulfotransferase genes important in maintaining the balance of active sex steroids in the liver. The Std locus encoding dehydroepiandrosterone sulfotransferase was mapped to proximal Chromosome 7, and the Ste locus encoding estrogen sulfotransferase was mapped to Chromosome 5. The db mutation in the diabetes-susceptible C57BL/KsJ strain aberrantly regulated mRNA transcript levels from these two loci. Hepatic Ste mRNA transcripts were increased from undetectable levels in normal males and females to high levels in db/db mice of both sexes. An anomalous suppression of Std transcription was observed in db/db females, but not in normal females. These reciprocal changes in mRNA concentrations in mutant females were reflected by an induction of a high affinity estrogen sulfotransferase activity and a concomitant loss of dehydroepiandrosterone sulfotransferase activity. These db gene-elicited effects were specific for the sex steroid sulfotransferases since other potential sex steroid metabolizing enzymes (phenol sulfotransferase, sex steroid sulfohydrolase, and UDP-glucuronyltransferase) were unaffected. These aberrant changes would virilize hepatic metabolism in females by increasing the ratio of active androgens to estrogens. In human females, non-insulin-dependent diabetes mellitus often develops when visceral obesity and hyperinsulinemia are associated with hyperandrogenization. This study demonstrates that background modifier genes interacting deleteriously with an obesity mutation are not necessarily defective alleles. Rather, some are functional genes whose regulation has been altered by pleiotropic effects of the obesity gene.

Cited by

Kennon AM, Stewart JA.
Front Physiol. 2021 Jun 07;12:676727. doi: 10.3389/fphys.2021.676727. eCollection 2021.
PMID: 34163373

References

  1. Proc Soc Exp Biol Med. 1992 Mar;199(3):265-72 - PubMed
  2. Trends Pharmacol Sci. 1991 Jul;12(7):255-9 - PubMed
  3. Mol Endocrinol. 1992 Apr;6(4):589-97 - PubMed
  4. Genetics. 1992 Jun;131(2):423-47 - PubMed
  5. Mol Pharmacol. 1992 Aug;42(2):257-64 - PubMed
  6. FASEB J. 1992 Sep;6(12):3073-5 - PubMed
  7. Mamm Genome. 1992;3(10):537-45 - PubMed
  8. Biochem J. 1993 Jan 1;289 ( Pt 1):233-40 - PubMed
  9. Mamm Genome. 1993;4(2):69-77 - PubMed
  10. Diabetes Metab Rev. 1992 Oct;8(3):179-208 - PubMed
  11. Am J Physiol. 1993 Mar;264(3 Pt 1):E342-7 - PubMed
  12. Ann N Y Acad Sci. 1993 Mar 15;676:242-52 - PubMed
  13. Crit Rev Food Sci Nutr. 1993;33(4-5):333-8 - PubMed
  14. Genomics. 1993 Nov;18(2):440-3 - PubMed
  15. Diabetologia. 1974 Nov;10 Suppl:607-10 - PubMed
  16. Arch Biochem Biophys. 1983 Nov;227(1):248-58 - PubMed
  17. Gene. 1985;36(1-2):15-25 - PubMed
  18. Immunogenetics. 1987;26(1-2):6-13 - PubMed
  19. Metabolism. 1987 Sep;36(9):863-9 - PubMed
  20. Endocrinology. 1989 Feb;124(2):912-22 - PubMed
  21. Diabetes Metab Rev. 1989 Mar;5(2):83-109 - PubMed
  22. FASEB J. 1989 Sep;3(11):2231-41 - PubMed
  23. Genetics. 1990 Feb;124(2):221-36 - PubMed
  24. J Hered. 1990 Nov-Dec;81(6):424-7 - PubMed
  25. Mol Pharmacol. 1991 Mar;39(3):414-20 - PubMed
  26. J Clin Invest. 1991 Apr;87(4):1286-94 - PubMed
  27. Diabetes. 1991 Jan;40(1):123-8 - PubMed
  28. Diabetes. 1991 Jul;40(7):842-9 - PubMed
  29. Diabetes. 1991 Oct;40(10):1360-3 - PubMed
  30. Life Sci. 1992;50(12):857-61 - PubMed

Substances

MeSH terms

Publication Types

Grant support

LinkOut - more resources